<code id='C9711F66B9'></code><style id='C9711F66B9'></style>
    • <acronym id='C9711F66B9'></acronym>
      <center id='C9711F66B9'><center id='C9711F66B9'><tfoot id='C9711F66B9'></tfoot></center><abbr id='C9711F66B9'><dir id='C9711F66B9'><tfoot id='C9711F66B9'></tfoot><noframes id='C9711F66B9'>

    • <optgroup id='C9711F66B9'><strike id='C9711F66B9'><sup id='C9711F66B9'></sup></strike><code id='C9711F66B9'></code></optgroup>
        1. <b id='C9711F66B9'><label id='C9711F66B9'><select id='C9711F66B9'><dt id='C9711F66B9'><span id='C9711F66B9'></span></dt></select></label></b><u id='C9711F66B9'></u>
          <i id='C9711F66B9'><strike id='C9711F66B9'><tt id='C9711F66B9'><pre id='C9711F66B9'></pre></tt></strike></i>

          knowledge

          knowledge

          author:knowledge    Page View:17799

          Editor’s note: A recording of the event is embedded below.

          After a few go-go years, the early-stage biotech market has cooled considerably. Two VCs will weigh in on what distinguishes great science from bad investments.

          advertisement

          Featured Speakers

          • Irena Melnikova, Ph.D., partner, Pfizer Ventures
          • Rakhshita Dhar, senior director, venture investments, Leaps by Bayer
          • Frank S. David, M.D., Ph.D., managing director, Pharmagellan (moderator)

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more
          How to make Best Hospitals ratings actually useful for patients
          How to make Best Hospitals ratings actually useful for patients

          AdobeU.S.News&WorldReport recentlyissuedits2023-24BestHospitalsratings.Theratingscomeatatimeofin

          read more
          How to save PrEP access — and even expand it
          How to save PrEP access — and even expand it

          UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

          read more

          Three trends to watch in biotech in 2024

          ChristineKao/STATEverywinter,likePunxsutawneynobles,biotech’smanythoughtleadersgatherfortheJ.P.Morga